Free-cash-flow proxy decreased 33.9%
Free-cash-flow proxy changed -33.9% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed -33.9% from the comparable as-filed period.
Operating cash flow changed -34.6% from the comparable as-filed period.
Current assets changed +112.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Total assets changed +110.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed -17.2% from the comparable as-filed period.
Current ratio changed +233.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital changed +211.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed +59.0% from the comparable as-filed period.
Current liabilities changed -36.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Trade receivables changed +20.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Capital expenditure changed -94.0% from the comparable as-filed period.
Research & development changed +17.4% from the comparable as-filed period.
Working capital / assets changed +2582 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Shares outstanding changed +18.0% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
Cash & equivalents changed +0.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Total assets changed +121.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +127.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed +290.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -39.9% from the comparable as-filed period.
Current liabilities changed -41.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -264183 basis points from the comparable as-filed period.
Revenue changed -73.9% from the comparable as-filed period.
Cash & equivalents changed +76.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Trade receivables changed -45.1% from the comparable as-filed period.
Stock-based compensation changed +73.2% from the comparable as-filed period.
Working capital changed +235.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -17.6% from the comparable as-filed period.
Capex / revenue changed +3539 basis points from the comparable as-filed period.
SBC / revenue changed +40118 basis points from the comparable as-filed period.
Capital expenditure changed +188.9% from the comparable as-filed period.
Operating cash flow changed -16.5% from the comparable as-filed period.
Research & development changed +18.0% from the comparable as-filed period.
Shares outstanding changed +23.8% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
Operating cash-flow margin changed -182943 basis points from the comparable as-filed period.
Free-cash-flow margin changed -186482 basis points from the comparable as-filed period.
Working capital / assets changed +2785 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
R&D / revenue changed +175791 basis points from the comparable as-filed period.
Receivables / revenue changed +2050 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.